Maricann Group Inc Share Price Deutsche Boerse AG
Equities
CA5667241007
Pharmaceuticals
Sales 2016 | 4.06 3.77 319.03 | Sales 2017 | 3.22 2.99 253.23 | Capitalization | 203M 189M 15.97B |
---|---|---|---|---|---|
Net income 2016 | -8M -7.43M -629M | Net income 2017 | -67M -62.23M -5.26B | EV / Sales 2016 * | - |
Net Debt 2016 | 9.13 8.48 717.24 | Net cash position 2017 | 0.42 0.39 32.85 | EV / Sales 2017 | 63,046,727 x |
P/E ratio 2016 * |
-
| P/E ratio 2017 |
-2.13
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
Dan Healey
COO | Chief Operating Officer | - | - |
Steven Bennett
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
1st Jan change | Capi. | |
---|---|---|
+41.50% | 6.2B | |
-22.89% | 4.1B | |
+9.36% | 3.41B | |
-19.39% | 2.83B | |
-11.05% | 2.29B | |
+45.24% | 1.93B | |
-7.51% | 1.52B | |
+46.81% | 1.51B | |
-18.04% | 1.49B |